Ligandal

Ligandal is a private, preclinical-stage biotech building a foundational 'Delivery OS' for precision medicine. Its core LigandAI™ platform uses predictive interactomics and computational design to engineer peptides that direct therapeutic payloads to disease sites with high specificity. The company's mission is to solve the delivery challenge for next-generation therapeutics, enabling cures by targeting the molecular roots of disease rather than just managing symptoms.

AI-powered peptide design platform (LigandAI™) for creating targeting ligands that direct lipid nanoparticles and other delivery vehicles to specific molecular and cellular targets. Core technology is Peptide Direct Conjugate (PDC) technology.

Ligandal competes in the targeted drug delivery space against companies developing alternative targeting moieties (antibodies, aptamers, other peptides), novel lipid nanoparticle formulations, and viral vector engineering for gene therapy. Its differentiation is the AI-driven, generative design of its peptide ligands and its focus on creating a universal 'Delivery OS' platform.